02.09.2012 • News

Bayer CEO Says Greek Euro Exit May Help

Leaving the euro zone could help Greece to recover economically and prevent the region's debt crisis from spreading, the head of German drugmaker Bayer was quoted as saying in a newspaper interview on Saturday.

The comments from Bayer CEO Marijn Dekkers add to a growing chorus of influential Germans speculating about the possible exit of Greece from the euro zone, despite Chancellor Angela Merkel's request for compatriots to tone down their rhetoric.

"Greece's exit from the euro may be better for all parties involved," Dekkers said, according to the Rheinische Post.

With its own currency, Greece might stand a better chance of escaping its economic slump, while keeping the euro strong would prevent a domino effect that could hit Spain and Portugal, Dekkers was quoted as saying.

He also said that if the drugs Bayer is developing are as successful as planned the company might become a top ten pharma company worldwide.

As a result, the company had no need to make a large takeover or merge with a competitor, he said.

Dekkers would neither sell nor seek to merge the Bayer MaterialScience unit with Lanxess or Evonik, he was quoted as saying.

 

Virtual Event

Outsourced Biomanufacturing
Strategic Outsourcing in Biopharmaceuticals

Outsourced Biomanufacturing

April 22, 2026 | Join biopharma professionals, CDMO leaders, and supply chain innovators for a virtual event exploring the future of outsourced biomanufacturing.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.